摘要
Kai Xin San(KXS, containing ginseng, hoelen, polygala, and acorus), a traditional Chinese herbal compound, has been found to regulate cognitive dysfunction; however, its mechanism of action is still unclear. In this study, 72 specific-pathogen-free male Kunming mice aged 8 weeks were randomly divided into a vehicle control group, scopolamine group, low-dose KXS group, moderate-dose KXS group, high-dose KXS group, and positive control group. Except for the vehicle control group and scopolamine groups(which received physiological saline), the doses of KXS(0.7, 1.4 and 2.8 g/kg per day) and donepezil(3 mg/kg per day) were gastrointestinally administered once daily for 2 weeks. On day 8 after intragastric treatment, the behavioral tests were carried out. Scopolamine group and intervention groups received scopolamine 3 mg/kg per day through intraperitoneal injection. The effects of KXS on spatial learning and memory, pathological changes of brain tissue, expression of apoptosis factors, oxidative stress injury factors, synapse-associated protein, and cholinergic neurotransmitter were measured. The results confirmed the following.(1) KXS shortened the escape latency and increased residence time in the target quadrant and the number of platform crossings in the Morris water maze.(2) KXS increased the percentage of alternations between the labyrinth arms in the mice of KXS groups in the Y-maze.(3) Nissl and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining revealed that KXS promoted the production of Nissl bodies and inhibited the formation of apoptotic bodies.(4) Western blot assay showed that KXS up-regulated the expression of anti-apoptotic protein Bcl-2 and inhibited the expression of pro-apoptotic protein Bax. KXS up-regulated the expression of postsynaptic density 95, synaptophysin, and brain-derived neurotrophic factor in the cerebral cortex and hippocampus.(5) KXS increased the level and activity of choline acetyltransferase, acetylcholine, superoxide dismutase, and glutathione peroxidase, and reduced the level and activity of acetyl cholinesterase, reactive oxygen species, and malondialdehyde through acting on the cholinergic system and reducing oxidative stress damage. These results indicate that KXS plays a neuroprotective role and improves cognitive function through reducing apoptosis and oxidative stress, and regulating synapse-associated protein and cholinergic neurotransmitters.
Kai Xin San(KXS, containing ginseng, hoelen, polygala, and acorus), a traditional Chinese herbal compound, has been found to regulate cognitive dysfunction; however, its mechanism of action is still unclear. In this study, 72 specific-pathogen-free male Kunming mice aged 8 weeks were randomly divided into a vehicle control group, scopolamine group, low-dose KXS group, moderate-dose KXS group, high-dose KXS group, and positive control group. Except for the vehicle control group and scopolamine groups(which received physiological saline), the doses of KXS(0.7, 1.4 and 2.8 g/kg per day) and donepezil(3 mg/kg per day) were gastrointestinally administered once daily for 2 weeks. On day 8 after intragastric treatment, the behavioral tests were carried out. Scopolamine group and intervention groups received scopolamine 3 mg/kg per day through intraperitoneal injection. The effects of KXS on spatial learning and memory, pathological changes of brain tissue, expression of apoptosis factors, oxidative stress injury factors, synapse-associated protein, and cholinergic neurotransmitter were measured. The results confirmed the following.(1) KXS shortened the escape latency and increased residence time in the target quadrant and the number of platform crossings in the Morris water maze.(2) KXS increased the percentage of alternations between the labyrinth arms in the mice of KXS groups in the Y-maze.(3) Nissl and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining revealed that KXS promoted the production of Nissl bodies and inhibited the formation of apoptotic bodies.(4) Western blot assay showed that KXS up-regulated the expression of anti-apoptotic protein Bcl-2 and inhibited the expression of pro-apoptotic protein Bax. KXS up-regulated the expression of postsynaptic density 95, synaptophysin, and brain-derived neurotrophic factor in the cerebral cortex and hippocampus.(5) KXS increased the level and activity of choline acetyltransferase, acetylcholine, superoxide dismutase, and glutathione peroxidase, and reduced the level and activity of acetyl cholinesterase, reactive oxygen species, and malondialdehyde through acting on the cholinergic system and reducing oxidative stress damage. These results indicate that KXS plays a neuroprotective role and improves cognitive function through reducing apoptosis and oxidative stress, and regulating synapse-associated protein and cholinergic neurotransmitters.
引文
Aliev G,Priyadarshini M,Reddy VP,Grieg NH,Kaminsky Y,Cacabelos R,Ashraf GM,Jabir NR,Kamal MA,Nikolenko VN,Zamyatnin AA,Jr.,Benberin VV,Bachurin SO(2014)Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease.Curr Med Chem 21:2208-2217.
Bayer AJ,Bullock R,Jones RW,Wilkinson D,Paterson KR,Jenkins L,Millais SB,Donoghue S(2005)Evaluation of the safety and immunogenicity of synthetic Abeta42(AN1792)in patients with AD.Neurology 64:94.
Beatty WW,Butters N,Janowsky DS(1986)Patterns of memory failure after scopolamine treatment:Implications for cholinergic hypotheses of dementia.Behav Neural Biol 45:196-211.
Boyle PA,Buchman AS,Wilson RS,Kelly JF,Bennett DA(2010)The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.Neuroepidemiology 34:43-49.
Brandeis R,Brandys Y,Yehuda S(1989)The use of the Morris Water Maze in the study of memory and learning.Int J Neurosci 48:29-69.
Budzynska B,Boguszewska-Czubara A,Kruk-Slomka M,Skalicka-Wozniak K,Michalak A,Musik I,Biala G(2015)Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice.Psychopharmacology 232:931-942.
Cao Y,Hu Y,Liu P,Zhao HX,Zhou XJ,Wei YM(2012)Effects of a Chinese traditional formula kai xin san(kxs)on chronic fatigue syndrome mice induced by forced wheel running.J Ethnopharmacol 139:19-25.
Chen W,Cheng X,Chen J,Yi X,Nie D,Sun X,Qin J,Tian M,Jin G,Zhang X(2014)Lycium barbarum polysaccharides prevent memory and neurogenesis impairments in scopolamine-treated rats.PLoSOne 9:e88076.
Dang H,Sun L,Liu X,Peng B,Wang Q,Jia W,Chen Y,Pan A,Xiao P(2009)Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress.Exp Biol Med 234:785-793.
Di YQ,Sang XX,Fang F(2017)Effects of Kaixin Powder on LTP in vivo and expression of PSD-95 in APP/PSl transgenic mice.Zhong Cheng Yao 471-475.
Dong L,May BH,Feng M,Hyde AJ,Tan HY,Guo X,Zhang AL,Lu C,Xue CC(2016a)Chinese herbal medicine for mild cognitive impairment:a systematic review and meta-analysis of cognitive outcomes.Phytother Res 30:1592-1604.
Dong XZ,Wang DX,Yu BY,Liu P,Hu Y(2016b)Kai-Xin-San,a traditional Chinese medicine formulation,exerts antidepressive and neuroprotective effects by promoting pCREB upstream pathways.Exp Ther Med 12:3308-3314.
Feldman HH et al.(2007)Effect of rivastigmine on delay to diagnosis of Alzheimer’s disease from mild cognitive impairment:the InD-DEx study.Lancet Neurol 6:501-512.
Goldsmith KC,Gross M,Peirce S,Luyindula D,Liu X,Vu A,Sliozberg M,Guo R,Zhao H,Reynolds CP,Hogarty MD(2012)Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma.Cancer Res 72:2565-2577.
Hescham S,Temel Y,Casacacarreira J,Arslantas K,Yakkioui Y,Blokland A,Jahanshahi A(2014)A neuroanatomical analysis of the effects of a memory impairing dose of scopolamine in the rat brain using cytochrome c oxidase as principle marker.J Chem Neuroanat 59-60:1-7.
Himeno E,Ohyagi Y,Ma L,Nakamura N,Miyoshi K,Sakae N,Motomura K,Soejima N,Yamasaki R,Hashimoto T,Tabira T,LaFerla FM,Kira J(2011)Apomorphine treatment in Alzheimer mice promoting amyloid-beta degradation.Annals Neurol 69:248-256.
Holmes C,Boche D,Wilkinson D,Yadegarfar G,Hopkins V,Bayer A,Jones RW,Bullock R,Love S,Neal JW,Zotova E,Nicoll JA(2008)Long-term effects of Abeta42 immunisation in Alzheimer’s disease:follow-up of a randomised,placebo-controlled phase I trial.Lancet372:216-223.
Holtzman DM(2008)Alzheimer’s disease:moving towards a vaccine.Nature 454:418-420.
Hu Y,Cao Y,Liu M,Liu P,Cui H,Dai-Hong G(2013a)Behavioral and biochemical effects of a formulation of the traditional Chinese medicine,Kai-Xin-San,in fatigued rats.Exp Ther Med 6:973-976.
Hu Y,Liu P,Guo DH,Rahman K,Wang DX,Chen ML,Xie TT(2010)Behavioral and biochemical effects of Kaixin-San,a traditional Chinese medicinal empirical formula.Drug Develop Res 69:267-271.
Hu Y,Liu M,Liu P,Yan JJ,Liu MY,Zhang GQ,Zhou XJ,Yu BY(2013b)Effect of kai xin san on learning and memory in a rat model of paradoxical sleep deprivation.J Med Food 16:280-287.
Ishola IO,Tota S,Adeyemi OO,Agbaje EO,Narender T,Shukla R(2013)Protective effect of Cnestis ferruginea and its active constituent on scopolamine-induced memory impairment in mice:a behavioral and biochemical study.Pharm Biol 51:825-835.
Jahanshahi M,Nickmahzar EG,Babakordi F(2013)Effect of Gingko biloba extract on scopolamine-induced apoptosis in the hippocampus of rats.Anat Sci Int 88:217-222.
Ji RF,Niu JZ,Xu AQ(2006)Determining the effects of Chinese medicine on Amnesia and/or dementias through data Mining.Zhongri Youhao Yiyuan Xuebao 20:337-340.
Kilimann I,Hausner L,Fellgiebel A,Filippi M,Wurdemann TJ,Heinsen H,Teipel SJ(2017)Parallel atrophy of cortex and basal forebrain cholinergic system in mild cognitive impairment.Cereb Cortex 27:1841-1848.
Kim DH,Jeon SJ,Son KH,Jung JW,Lee S,Yoon BH,Lee JJ,Cho YW,Cheong JH,Ko KH,Ryu JH(2007)The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice.Neurobiol Learn Mem 87:536-546.
Kim DH,Park SJ,Kim JM,Jeon SJ,Kim DH,Cho YW,Son KH,Lee HJ,Moon JH,Cheong JH,Ko KH,Ryu JH(2011)Cognitive dysfunctions induced by a cholinergic blockade and Abeta 25-35 peptide are attenuated by salvianolic acid B.Neuropharmacology 61:1432-1440.
Kopelman MD,Corn TH(1988)Cholinergic‘blockade’as a model for cholinergic depletion.A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome.Brain 111:1079-1110.
Kulshreshtha A,Piplani P(2016)Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction.Eur J Med Chem 122:557-573.
Li ZL,Dong XZ,Wang DX,Dong RH,Guo TT,Sun Y,Liu P(2014)Effect of oligosaccharide esters and polygalaxanthone III from Polygala tenuifolia willd towards cytochrome P450.Zhongguo Zhongyao Zazhi 39:4459.
Lian W,Fang J,Xu L,Zhou W,Kang,Xiong W,Jia H,Liu AL,Du GH(2017)DL0410 Ameliorates memory and cognitive impairments induced by scopolamine via increasing cholinergic neurotransmission in mice.Molecules 22:410.
Lim HW,Kumar H,Kim BW,More SV,Kim IW,Park JI,Park SY,Kim SK,Choi DK(2014)β-asarone(cis-2,4,5-trimethoxy-1-allyl phenyl),attenuates pro-inflammatory mediators by inhibiting nf-κb signaling and the jnk pathway in lps activated bv-2 microglia cells.Food Chem Toxicol 72:265-272.
Lin JK(2011)Active constituent and safety study of polygala tenuifolia willd.Beijing:Zhongguo Zhongyi Kexueyuan.
Lin ZY,Huang TW,Huang JS,Zheng GY,Kai-Long FU,Chen XY,Lin K(2015)Nourishing Xin and Shen method improved mild cognitive impairment due to subcortical small vessel disease:a clinical study.Zhongguo Zhong Xi Yi Jie He Za Zhi 35:41-45.
Lu C,Shi Z,Sun X,Pan R,Chen S,Li Y,Qu L,Sun L,Dang H,Bu L,Chen L,Liu X(2017)Kai Xin San aqueous extract improves Abeta1-40-induced cognitive deficits on adaptive behavior learning by enhancing memory-related molecules expression in the hippocampus.J Ethnopharmacol 201:73-81.
Malek-Ahmadi M(2016)Reversion from mild cognitive impairment to normal cognition:a meta-analysis.Alz Dis Assoc Dis 30:324-330.
Morris R(1984)Developments of a water-maze procedure for studying spatial learning in the rat.J Neurosci Meth 11:47-60.
Mu LH,Huang ZX,Liu P,Hu Y,Gao Y(2011)Acute and subchronic oral toxicity assessment of the herbal formula kai-xin-san.J Ethnopharmacol 138:351-357.
Mufson EJ,Counts SE,Perez SE,Ginsberg SD(2008)Cholinergic system during the progression of Alzheimer’s disease:therapeutic implications.Expert Rev Neurother 8:1703-1718.
Peng F,Cui YB,Song WY,Zhang JW,Liu JB,Guan FX(2017)Effect of radix polygalae on learning and memory ability of Alzheimer’s disease mice.Zhengzhou Daxue Xuebao 407-412.
Petersen RC(2004)Mild cognitive impairment as a diagnostic entity.J Intern Med 256:183-194.
Petersen RC,Thomas RG,Grundman M,Bennett D,Doody R,Ferris S,Galasko D,Jin S,Kaye J,Levey A,Pfeiffer E,Sano M,van Dyck CH,Thal LJ(2005)Vitamin E and donepezil for the treatment of mild cognitive impairment.New Engl J Med 352:2379-2388.
Qiong W,Yong-Liang Z,Ying-Hui L,Shan-Guang C,Jiang-Hui G,YiXi C,Ning J,Xin-Min L(2016)The memory enhancement effect of Kai Xin San on cognitive deficit induced by simulated weightlessness in rats.J Ethnopharmacol 187:9-16.
Ray NJ,Metzler-Baddeley C,Khondoker MR,Grothe MJ,Teipel S,Wright P,Heinsen H,Jones DK,Aggleton JP,O’Sullivan MJ(2015)Cholinergic basal forebrain structure influences the reconfiguration of white matter connections to support residual memory in mild cognitive impairment.J Neurosci 35:739-747.
Richter N,Michel A,Onur OA,Kracht L,Dietlein M,Tittgemeyer M,Neumaier B,Fink GR,Kukolja J(2017)White matter lesions and the cholinergic deficit in aging and mild cognitive impairment.Neurobiol Aging 53:27-35.
Ringman JM,Medina LD,Rodriguez-Agudelo Y,Chavez M,Lu P,Cummings JL(2009)Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer’s disease.Curr Alzheimer Res 6:341-346.
Salloway S,Ferris S,Kluger A,Goldman R,Griesing T,Kumar D,Richardson S(2004)Efficacy of donepezil in mild cognitive impairment A randomized placebo-controlled trial.Neurology 63:651.
Schuff N,Suhy J,Goldman R,Xu Y,Sun Y,Truran-Sacrey D,Murthy A(2011)An MRI substudy of a donepezil clinical trial in mild cognitive impairment.Neurobiol Aging 32:2318-2341.
Seabrook GR,Ray WJ,Shearman M,Hutton M(2007)Beyond amyloid:the next generation of Alzheimer’s disease therapeutics.Mol Interv 7:261-270.
Shi R,Zong X,Teng JL,Ji XM,Wang ZH(2017)Effect of Kai Xin San on neurotransmitter in SAMP8 mice.Zhongguo Laonianxue Zazhi37:5249-5251.
Sui Z,Qi C,Huang Y,Ma S,Wang X,Le G,Sun J(2017)Aqueous extracts from asparagus stems prevent memory impairments in scopolamine-treated mice.Food Funct 8:1460-1467.
Tschanz JT,Welsh-Bohmer KA,Lyketsos CG,Corcoran C,Green RC,Hayden K,Norton MC,Zandi PP,Toone L,West NA,Breitner JC(2006)Conversion to dementia from mild cognitive disorder:the cache county study.Neurology 67:229-234.
Wen ZL,Wang ZZ,He WB,Chen NH(2014)Protective effect of kaixin powder containing serum on corticosterone induced CTX TNA2cells injury.Shenjing Yaoli Xuebao 4:1-5.
Wilcock DM,Gharkholonarehe N,Van Nostrand WE,Davis J,Vitek MP,Colton CA(2009)Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer’s disease.J Neurosci 29:7957-7965.
Winblad B,Gauthier S,Scinto L,Feldman H,Wilcock GK,Truyen L,Mayorga AJ,Wang D,Brashear HR,Nye JS(2008)Safety and efficacy of galantamine in subjects with mild cognitive impairment.Neurology 70:2024-2035.
Xiang GQ,Tang SS,Jiang LY,Hong H,Li Q,Wang C,Wang XY,Zhang TT,Yin L(2012)PPARγagonist pioglitazone improves scopolamine-induced memory impairment in mice.J Pharm Pharmacol 64:589.
Xu QQ,Xu YJ,Yang C,Tang Y,Li L,Cai HB,Hou BN,Chen HF,Wang Q,Shi XG,Zhang SJ(2016)Sodium tanshinone IIA sulfonate attenuates scopolamine-induced cognitive dysfunctions via improving cholinergic system.BioMed Res Int 2016:9852536.
Ye MS,Zhao DJ,Zhou Y,Jiang LY(2017)Effect of ginsenoside Rg1onβ-amyloid induced neuron apoptosis.Zhejiang Zhongxiyi Jiehe Zazhi 27:642-645.
Yu P,Qu CH,Li XW,Guo CY(2008)The relationship between acetylcholine in brain and cognitive.Advances in Psychological Science03:453-457.
Zhang M,Wang W,Liu XJ,Huang FY(2016)Improvement effects of polygala saponins and pachymaran on spatial learning and memory ability in model mice and its mechanism.Beihua Daxue Xuebao(Ziran Kexueban)17:492-495.
Zhang SJ,Luo D,Li L,Tan RR,Xu QQ,Qin J,Zhu L,Luo NC,Xu TT,Zhang R,Yang L,Wang Q(2017a)Ethyl acetate extract components of Bushen-Yizhi formula provides neuroprotection against scopolamine-induced cognitive impairment.Sci Rep 7:9824.
Zhang SJ,Xu TT,Li L,Xu YM,Qu ZL,Wang XC,Huang SQ,Luo Y,Luo NC,Lu P,Shi YF,Yang X,Wang Q(2017b)Bushen-Yizhi formula ameliorates cognitive dysfunction through SIRT1/ER stress pathway in SAMP8 mice.Oncotarget 8:49338-49350.
Zhang XA(2016)Cortical mechanism underlying aerobic exercise promoting cognitive function of vascular dementia rats:study protocol for a randomized controlled trial.Zhongguo Zuzhi Gongcheng Yanjiu 20:6943-6949.
Zhou XJ,Liu M,Yan JJ,Cao Y,Liu P(2012)Antidepressant-like effect of the extracted of Kai Xin San,a traditional Chinese herbal prescription,is explained by modulation of the central monoaminergic neurotransmitter system in mouse.J Ethnopharmacol 139:422-428.
Zhu KY,Xu SL,Choi CY,Yan AL,Dong TX,Tsim KW(2013)Kaixin-san,a Chinese herbal decoction containing ginseng radix et rhizoma,polygalae radix,acori tatarinowii rhizoma,and poria,stimulates the expression and secretion of neurotrophic factors in cultured astrocytes.Evid-Based Compl Alt 2013:731385.
Zhu Y,Duan X,Cheng X,Cheng X,Li X,Zhang L,Liu P,Su S,Duan JA,Dong TT,Tsim KW,Huang F(2016)Kai-Xin-San,a standardized traditional Chinese medicine formula,up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron.J Ethnopharmacol 193:423-432.